Explore the detailed record of transactions filed by 이제중, Chief Executive Officer. Officer active across 2 companies, notably 박셀바이오. Aggregated, 23 filings have been logged. History available since 25 March 2026. The latest transaction was filed on 25 March 2026 (Purchase). Regulator: DART (FSS). The full history is accessible without signup.
Lee Je-jung is the CEO of Paxel Bio, where he leads the company towards innovation and growth. With extensive experience in the sector, he is responsible for overall strategy and operations management. His dynamic leadership is essential in positioning Paxel Bio as a key player in the industry.